Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

, AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

13:17
08/17/17
08/17
13:17
08/17/17
13:17

Tesaro drops 2% after FDA approves new dose for AstraZeneca's Lynparza

TSRO

Tesaro

$112.99

-1.01 (-0.89%)

AZN

AstraZeneca

$29.12

-0.0637 (-0.22%)

  • 06

    Sep

  • 08

    Sep

  • 08

    Sep

TSRO Tesaro
$112.99

-1.01 (-0.89%)

08/16/17
EVER
08/16/17
INITIATION
Target $121
EVER
In Line
Tesaro initiated with an In Line at Evercore ISI
Evercore ISI analyst Josh Schimmer initiated Tesaro with an In Line and a $121 price target.
08/09/17
LEER
08/09/17
NO CHANGE
Target $143
LEER
Market Perform
Tesaro Zejula off to 'strong initial launch, says Leerink
Leerink analyst Seamus Fernandez notes that Tesaro (TSRO) reported Q2 earnings with $25.9M in Zejula sales during its first quarter on the market following approval for second-line or greater ovarian cancer maintenance, more than doubling consensus estimates. With more than 1,500 new patient starts in the quarter, Zejula is off to a "strong" initial launch, he adds. However, the analyst believes it will likely soon face competition from Clovis' (CLVS) Rubraca and AstraZeneca's (AZN) Lynparza following their likely approvals in this setting. Fernandez reiterates a Market Perform rating and $143 price target on Tesaro's shares.
08/08/17
MSCO
08/08/17
NO CHANGE
MSCO
Morgan Stanley buyers of Clovis and Tesaro into Lynparza label decision
Morgan Stanley analyst Andrew Berens would be a buyer of Clovis (CLVS) and Tesaro (TSRO) ahead of the broad label decision for AstraZeneca's (AZN) Lynparza in 2L maintenance setting expected in Q3. Berens sees minimal fundamental impact to both stocks, even if AstraZeneca receives a broad label. He thinks a broad label will be limited to BRCA patients, or the FDA will place caveats as having inferior data outside of BRCA, and both stocks will benefit as an overhang is lifted.
08/01/17
JANY
08/01/17
NO CHANGE
JANY
Neutral
Robust launch for Idhifa already reflected in Agios shares, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay said he anticipates rapid adoption of Idhifa and expects a robust commercial launch led by Agios' (AGIO) partner Celgene (CELG), but he also believes this is reflected in the stock. The wholesale acquisition cost of $24,872 is significantly higher than Tesaro's (TSRO) Zejula and Clovis' (CLVS) Rubraca, noted Chattopadhyay, who added that the higher WAC and potentially longer median duration of therapy represents upside to his current estimates. He keeps a Neutral rating on Agios, which will receive a low double digit to mid teens royalty for Idhifa.
AZN AstraZeneca
$29.12

-0.0637 (-0.22%)

08/09/17
PIPR
08/09/17
NO CHANGE
PIPR
Overweight
AstraZeneca recent selloff a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Richard Purkiss believes the recent negative MYSTIC update from AstraZeneca has created a long-term buying opportunity. 2017 marks an earnings trough year for the company, and the shares now trade at discounted valuation, Purkiss tells investors in a research note. He reiterates an Overweight rating on the shares with a GBP 51 price target.
08/01/17
PART
08/01/17
UPGRADE
PART
Hold
AstraZeneca upgraded to Hold from Sell at Pareto

TODAY'S FREE FLY STORIES

OPK

OPKO Health

$6.33

0.32 (5.32%)

12:05
09/21/17
09/21
12:05
09/21/17
12:05
Options
Opko Health call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

OFIX

Orthofix

$47.73

-0.78 (-1.61%)

11:58
09/21/17
09/21
11:58
09/21/17
11:58
Conference/Events
Orthofix management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 26

    Sep

LLEX

Lilis Energy

$3.99

-0.03 (-0.75%)

11:56
09/21/17
09/21
11:56
09/21/17
11:56
Conference/Events
Lilis Energy management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

11:55
09/21/17
09/21
11:55
09/21/17
11:55
General news
Treasury Action: month- and quarter-end are quickly sneaking up »

Treasury Action: month-…

ICFI

ICF International

$50.95

-0.25 (-0.49%)

11:54
09/21/17
09/21
11:54
09/21/17
11:54
Conference/Events
ICF International management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

, BNPQY

BNP Paribas

$39.58

-0.14 (-0.35%)

11:53
09/21/17
09/21
11:53
09/21/17
11:53
Periodicals
German government is favoring Commerzbank-BNP Paribas merger, CNBC says »

The German government is…

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

BNPQY

BNP Paribas

$39.58

-0.14 (-0.35%)

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.03

-0.12 (-0.66%)

11:50
09/21/17
09/21
11:50
09/21/17
11:50
Options
Put buyers active in Marvell as shares tick higher »

Put buyers active in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

TSLA

Tesla

$373.91

-1.19 (-0.32%)

11:48
09/21/17
09/21
11:48
09/21/17
11:48
Periodicals
Tesla to stop selling cheapest Model S this weekend, Business Insider says »

Tesla will stop offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

FANG

Diamondback Energy

$97.32

3.04 (3.22%)

11:45
09/21/17
09/21
11:45
09/21/17
11:45
Hot Stocks
Diamondback Energy EVP Molnar sells 5,000 shares »

Diamondback Energy's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FINL

Finish Line

$9.43

-0.13 (-1.36%)

11:40
09/21/17
09/21
11:40
09/21/17
11:40
Options
Large spread in Finish Line ahead of earnings »

Large spread in Finish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

11:40
09/21/17
09/21
11:40
09/21/17
11:40
General news
Oil Action: NYMEX crude »

Oil Action: NYMEX crude…

SQ

Square

$28.24

-0.23 (-0.81%)

, INTC

Intel

$37.07

-0.16 (-0.43%)

11:32
09/21/17
09/21
11:32
09/21/17
11:32
Hot Stocks
Square names Intel's Naveen Rao to board »

Square (SQ) announced…

SQ

Square

$28.24

-0.23 (-0.81%)

INTC

Intel

$37.07

-0.16 (-0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 05

    Oct

  • 22

    Oct

WASH

Washington Trust

$53.05

0.15 (0.28%)

11:31
09/21/17
09/21
11:31
09/21/17
11:31
Hot Stocks
Washington Trust increases quarterly dividend by 1c »

The board of Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

, CRZBY

Commerzbank

$13.02

0.28 (2.20%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Periodicals
UniCredit expresses interest in Commerzbank merger, Reuters reports »

UniCredit recently…

UNCFF

UniCredit

$21.15

-0.14 (-0.66%)

CRZBY

Commerzbank

$13.02

0.28 (2.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OIH

Oil Services Holders Trust

$24.86

-0.33 (-1.31%)

11:30
09/21/17
09/21
11:30
09/21/17
11:30
Options
Short-term call buyers drilling for profits in Market Vectors Oil Services Fund »

Short-term call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICPT

Intercept

$98.12

1.92 (2.00%)

11:29
09/21/17
09/21
11:29
09/21/17
11:29
Hot Stocks
Intercept sinks after FDA safety communication cites 19 patient deaths »

The FDA, in its safety…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOR

ShoreTel

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Hot Stocks
Breaking Hot Stocks news story on ShoreTel »

Gardner Lewis reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFX

Equifax

$97.46

1.46 (1.52%)

11:25
09/21/17
09/21
11:25
09/21/17
11:25
Periodicals
Equifax CEO to testify to Senate panel on October 4, Bloomberg says »

The Senate Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

FSLR

First Solar

$48.85

-0.01 (-0.02%)

, SPWR

SunPower

$7.86

-0.51 (-6.09%)

11:24
09/21/17
09/21
11:24
09/21/17
11:24
Hot Stocks
Before the Move: Watch First Solar, others ahead of ITC decision »

With an ITC Section 201…

FSLR

First Solar

$48.85

-0.01 (-0.02%)

SPWR

SunPower

$7.86

-0.51 (-6.09%)

CSIQ

Canadian Solar

$16.02

-0.69 (-4.13%)

JKS

JinkoSolar

$26.13

-0.16 (-0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNG

Golar LNG

$21.15

0.66 (3.22%)

11:20
09/21/17
09/21
11:20
09/21/17
11:20
Options
Golar LNG calls active as shares see relative strength »

Golar LNG calls active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
09/21/17
09/21
11:17
09/21/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
09/21/17
09/21
11:16
09/21/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$81.16

-0.64 (-0.78%)

11:15
09/21/17
09/21
11:15
09/21/17
11:15
Options
Capital One put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 07

    Nov

11:15
09/21/17
09/21
11:15
09/21/17
11:15
General news
Treasury announced an $88 B 3-pronged package of coupon auctions »

Treasury announced an $88…

PEG

PSEG

$46.31

1.08 (2.39%)

11:10
09/21/17
09/21
11:10
09/21/17
11:10
Conference/Events
PSEG management to meet with Evercore ISI »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 25

    Sep

  • 05

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.